CSF1R-IN-19
CSF1R-IN-19 is a potent inhibitor of CSF1R. CSF1R-IN-19 affects the exchange of inflammatory factors between TAMs and glioma cells. CSF1R-IN-19 has the potential for the research of cancer[1].
Product Specifications
CAS Number
1819989-27-9
UNSPSC
12352005
Target
C-Fms
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/csf1r-in-19.html
Solubility
10 mM in DMSO
Smiles
O[C@H](CC1)CC[C@@H]1N(N=C2)C=C2NC3=NC(C4CCCCC4)=CN5C3=NC=N5
Molecular Formula
C20H27N7O
Molecular Weight
381.47
References & Citations
[1]Michael M, et al. Heterocyclic kinase inhibitors. French, WO2015158283A1. 2015-10-22.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0844208 1.0 µg DNA
GBD2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
A06908-2-Cy3 100 µg/Vial
Anti-ENTPD5 Antibody Picoband® Cy3 Conjugated
Sign In for Pricing
View Details 
132823-APC 100 µL
RPS6KA3 (ISPK1, MAPKAPK1B, RSK2, Ribosomal Protein S6 Kinase alpha-3, 90kD Ribosomal Protein S6 Kinase 3, Insulin-stimulated Protein Kinase 1, MAP Kinase-activated Protein Kinase 1b, Ribosomal S6 Kinase 2, pp90RSK2) (APC)
Sign In for Pricing
View Details